Welcome to the RD&E Research Repository

The RD&E Research Repository contains research outputs from staff at the Royal Devon & Exeter NHS Foundation Trust.

You can browse items by Title, Author, Subject or Community/Collection, or use the search function to find specific topics.

The repository contains details of published, peer-reviewed journal articles, reviews, book chapters, conference abstracts, posters and more! Full-text of journal articles have been included where publisher's permissions allow.

If you are a member of RD&E staff and you'd like to submit an item to the repository, please fill in this online form. If you have a list of publications you'd like to submit, please e-mail the repository admin team: rde-tr.ResearchRepository@nhs.net.

For more information or help, please contact the RD&E Research Repository admin team:
Email: rde-tr.ResearchRepository@nhs.net
Telephone: Exeter Health Library, 01392 406800

  • Hospital admissions from alcohol-related acute pancreatitis during the COVID-19 pandemic: A single-centre study 

    Mak, W. K.; Di Mauro, D.; Pearce, E.; Karran, L.; Myintmo, A.; Duckworth, J.; Orabi, A.; Lane, R.; Holloway, S.; Manzelli, A.; Mossadegh, S. (IS Publishing, 2022-09-06)
    BACKGROUND: The United Kingdom government introduced lockdown restrictions for the first time on 23 March 2020 due to coronavirus disease 2019 (COVID-19) pandemic. These were partially lifted on 15 June and further eased ...
  • Using simulation and machine learning to maximise the benefit of intravenous thrombolysis in acute stroke in England and Wales: the SAMueL modelling and qualitative study 

    Allen, M.; James, C.; Frost, J.; Liabo, K.; Pearn, K.; Monks, T.; Zhelev, Z.; Logan, S.; Everson, R.; James, M.; Stein, K. (NIHR Journals Library, 2022-10-01)
    BACKGROUND: Stroke is a common cause of adult disability. Expert opinion is that about 20% of patients should receive thrombolysis to break up a clot causing the stroke. Currently, 11–12% of patients in England and Wales ...
  • EFSUMB Clinical Practice Guidelines for Point-of-Care Ultrasound: Part One (Common Heart and Pulmonary Applications) SHORT VERSION 

    Jarman, R. D.; Colclough, A.; McDermott, C.; Bøtker, M.; Knudsen, L.; Harris, T.; Albaroudi, B.; Albaroudi, O.; Haddad, M.; Darke, R.; Berry, E.; Breslin, T.; Fitzpatrick, G.; Flanagan, L.; Olusanya, O.; Craver, D.; Omar, A.; Simpson, T.; Cherian, N.; Dore, M.; Prosen, G.; Kay, S.; Villén-Villegas, T.; Gargani, L.; Carley, S.; Woo, M.; Dupriez, F.; Hussain, A.; Via, G.; Connolly, J. A.; Peck, M.; Melniker, L.; Walden, A.; Attard Biancardi, M. A.; Żmijewska-Kaczor, O.; Lalande, E.; Geukens, P.; McLaughlin, R.; Olszynski, P.; Hoffmann, B.; Chin, E.; Muhr, C.; Kim, D. J.; Mercieca, A.; Shukla, D.; Hayward, S.; Smith, M.; Gaspari, R.; Smallwood, N.; Pes, P.; Tavazzi, G.; Corradi, F.; Lambert, M.; Morris, C.; Trauer, M.; Baker, K.; Bystrzycki, A.; Goudie, A.; Liu, R.; Rudd, L.; Dietrich, C. F.; Jenssen, C.; Sidhu, P. S. (Thieme Gruppe, 2022-10-13)
    OBJECTIVE:  To evaluate the evidence and produce a summary and recommendations for the most common heart and lung point-of-care ultrasound (PoCUS). METHODS:  We reviewed 10 clinical domains/questions related to common heart ...
  • Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer 

    Einerhand, S. M. H.; Black, A. J.; Zargar, H.; Fairey, A. S.; Dinney, C. P.; Mir, M. C.; Krabbe, L. M.; Cookson, M. S.; Jacobson, N. E.; Montgomery, J. S.; Vasdev, N.; Yu, E. Y.; Xylinas, E.; Kassouf, W.; Dall'Era, M. A.; Sridhar, S. S.; McGrath, J. S.; Aning, J.; Shariat, S. F.; Wright, J. L.; Thorpe, A. C.; Morgan, T. M.; Holzbeierlein, J. M.; Bivalacqua, T. J.; North, S.; Barocas, D. A.; Lotan, Y.; Grivas, P.; Garcia, J. A.; Stephenson, A. J.; Shah, J. B.; Daneshmand, S.; Zargar-Shoshtari, K.; Spiess, P. E.; van Rhijn, B. W. G.; Black, P. C.; Mertens, L. S. (Springer, 2022-11-01)
    PURPOSE: Cisplatin-based chemotherapy followed by radical cystectomy (RC) is recommended in patients with muscle-invasive bladder cancer (MIBC). However, up to 50% of patients are cisplatin ineligible. The aim of this study ...
  • EFSUMB Clinical Practice Guidelines for Point-of-Care Ultrasound: Part One (Common Heart and Pulmonary Applications) LONG VERSION 

    Jarman, R. D.; McDermott, C.; Colclough, A.; Bøtker, M.; Knudsen, L.; Harris, T.; Albaroudi, B.; Albaroudi, O.; Haddad, M.; Darke, R.; Berry, E.; Breslin, T.; Fitzpatrick, G.; Flanagan, L.; Olusanya, O.; Craver, D.; Omar, A.; Simpson, T.; Cherian, N.; Dore, M.; Prosen, G.; Kay, S.; Villén-Villegas, T.; Gargani, L.; Carley, S.; Woo, M.; Dupriez, F.; Hussain, A.; Via, G.; Connolly, J. A.; Peck, M.; Melniker, L.; Walden, A.; Attard Biancardi, M. A.; Żmijewska-Kaczor, O.; Lalande, E.; Geukens, P.; McLaughlin, R.; Olszynski, P.; Hoffmann, B.; Chin, E.; Muhr, C.; Kim, D. J.; Mercieca, A.; Shukla, D.; Hayward, S.; Smith, M.; Gaspari, R.; Smallwood, N.; Pes, P.; Tavazzi, G.; Corradi, F.; Lambert, M.; Morris, C.; Trauer, M.; Baker, K.; Bystrzycki, A.; Goudie, A.; Liu, R.; Rudd, L.; Dietrich, C. F.; Jenssen, C.; Sidhu, P. S. (Thieme Gruppe, 2022-10-13)
    AIMS:  To evaluate the evidence and produce a summary and recommendations for the most common heart and lung applications of point-of-care ultrasound (PoCUS). METHODS:  We reviewed 10 clinical domains/questions related to ...

View more